Hydrogels for combination delivery of antineoplastic agents.
The systemic delivery of anticancer agents has been widely investigated during the past decade but localized delivery may offer a safer and more effective delivery approach. We have designed and synthesized a novel hydrogel to locally deliver antineoplastic agents, and demonstrate the different types of release that can be achieved from these hydrogels using three model drugs: methotrexate, doxorubicin, and mitoxantrone. Alginate was chemically modified into low molecular weight oligomers and cross-linked with a biodegradable spacer (adipic dihydrazide) to form biodegradable hydrogels. The model antineoplastic agents were loaded into the hydrogel via three different mechanisms. Methotrexate was incorporated within the pores of the hydrogel and was released by diffusion into the surrounding medium. Doxorubicin was covalently attached to the polymer backbone via a hydrolytically labile linker and was released following the chemical hydrolysis of the linker. Mitoxantrone was ionically complexed to the polymer and was released after the dissociation of this complex. These three release mechanisms could potentially be used to deliver a wide selection of antineoplastic agents, based on their chemical structure. This novel delivery system allows for the release of single or combinations of antineoplastic agents, and may find utility in localized antineoplastic agent delivery.
Bouhadir
K H
KH
Department of Biologic and Materials Sciences, University of Michigan, Ann Arbor 48109-2136, USA.
Alsberg
E
E
Mooney
D J
DJ
D000464:Alginates; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D020100:Hydrogels / Q000008:administration & dosage* / Q000138:chemical synthesis / Q000737:chemistry; D007700:Kinetics; D008727:Methotrexate / Q000008:administration & dosage / Q000737:chemistry; D008942:Mitoxantrone / Q000008:administration & dosage / Q000737:chemistry; D008954:Models, Biological; D010084:Oxidation-Reduction; D010710:Phosphates; D012965:Sodium Chloride
D000464:Alginates; D000970:Antineoplastic Agents; D004337:Drug Carriers; D006603:Hexuronic Acids; D020100:Hydrogels; D010710:Phosphates; D012965:Sodium Chloride; D004317:Doxorubicin; D020723:Glucuronic Acid; D008942:Mitoxantrone; C009285:sodium polymetaphosphate; D008727:Methotrexate